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Abstract 
Objective: Patients with dual hepatitis B (HBV) and hepatitis D (HDV) virus infection are at an increased risk of pro‑
gression to liver cirrhosis and hepatocellular carcinoma than patients with a single viral infection. Treatment of viral 
hepatitis due to dual HBV/HDV infection represents a challenge. Currently there is no vaccine against HDV. Recombi‑
nant production of HDV antigen (HDAg) is the first step towards a potential vaccine candidate and the development 
of assays for HDV detection.
Results: This study demonstrates the expression of one HDAg isoform, S‑HDAg, in Pichia pastoris. A recombinant 
vector carrying a tagged gene encoding S‑HDAg under the control of the methanol‑inducible promoter AOX1 was 
designed and integrated into P. pastoris X33. The protein, which was purified using a  Ni2+ affinity column and eluted 
at 100–150 mM imidazole, has potential as a recombinant antigen for further study.
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Introduction
It is estimated that ~240 million people are chronic 
hepatitis B surface antigen (HBsAg) carriers, of which 
~15–20 million are also infected with hepatitis delta 
virus (HDV) [1–3]. The HDV virion comprises an RNA 
genome, a single HDV-encoded antigen (HDAg) and a 
lipoprotein envelope provided by HBsAg [4–7]. HDAg 
comprises two isoforms, small HDAg (S-HDAg) and 
large HDAg (L-HDAg) [8, 9]. These two isoforms share 
the same core sequence, but L-HDAg is extended by an 
additional 19 amino acids at the carboxyl terminus of 
S-HDAg. S-HDAg may represent a candidate for human 
vaccine development. Protection induced by immuniza-
tion of adjuvanted S-HDAg (p24) was evaluated in wood-
chucks challenged with HDV by measuring humoral- and 
T cell-mediated responses to HDAg [10]. In another 
study, a DNA vaccine expressing S-HDAg generated a 
higher titer of anti-HDV antibodies than one expressing 
L-HDAg [11]. However, efforts to characterize and evalu-
ate the immunological properties of S-HDAg have been 
limited due to the lack of proper methods for efficient 
expression and purification of S-HDAg. In this work, we 
present a short procedure to express and detect S-HDAg 
in Pichia pastoris culture medium.
Main text
Methods
PCR amplification of the S‑HDAg gene
Two primers, HDAg-F: 5′-GCTCTAGATTTGG 
GAATCCCTGGTTTCC-3′ and HDAg-R: 5′-GCGG 
TACCATGAGCCGGTCCGAATCG-3′ (XbaI and KpnI 
sites underlined, respectively), were used to amplify 
the S-HDAg gene. The volume of the PCR reaction was 
50 µL including: 1× Phusion buffer, 0.2 mM dNTP (NEB, 
N0446S), 0.5  mM each primer (IDT) and 5  ng pHDV3 
plasmid as a template, 1U Phusion High-Fidelity DNA 
polymerase (NEB, M0530S). The PCR reaction was per-
formed by using the following program: 98 °C for 30 s; 30 
cycles of (98  °C for 10  s, 55  °C for 30  s, 72  °C for 30  s) 
and final extension at 72 °C for 5 min. The PCR product 
was analyzed by electrophoresis using a 1% (w/v) agarose 
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gel (BioBasic, D0012) and visualized by Red-Safe Solution 
(iNtRON, 21141) on a Blue LED Illuminator. The desired 
DNA band ~590 bp was excised from the gel and purified 
by QIAquick Gel Extraction Kit (Qiagen, 28706) follow-
ing manufacturer’s instructions.
Cloning of the S‑HDAg gene into pPICZαA
Enzymatic digestion and  ligation The purified S-HDAg 
gene and vector pPICZαA (TFS, V19520) were digested 
with XbaI and KpnI (NEB, R0145S and R0142S, respec-
tively) and purified by QIAquick PCR Purification Kit 
(Qiagen, 28106) following the manufacturer’s instruc-
tions. The digested HDAg gene was ligated into the lin-
earized vector pPICZαA using T4 DNA ligase (NEB, 
M0202S). The reaction was performed in a 20 µL volume 
including 2  µL 10× Rapid Ligation Buffer, 8  µL DNA 
(~100 ng), 1 µL 5 U/µL T4 DNA ligase and incubated at 
22 °C for 2 h.
Transformation and  screening of  E. coli 10  μL of the 
ligation mixture was transformed into competent E. coli 
DH5α cells by heat shock at 42 °C for 30 s. The cells were 
then recovered by adding 500 µL liquid LB medium and 
incubating at 37 °C for 1 h and then plated on LB plates 
supplemented with 25 μg/mL Zeocin (TFS, R25001). After 
incubated at 37 °C overnight, ten colonies were cultured 
in 3 mL liquid LB medium supplemented with 25 µg/mL 
Zeocin at 37  °C overnight. The recombinant plasmids 
were isolated from the cell pellets using a GeneJET Plas-
mid Miniprep kit (TFS, K0503) following the manufac-
turer’s instructions and digested using XbaI and KpnI for 
screening positive plasmids carrying the S-HDAg gene.
Sequencing and analysis
In order to confirm positive clones, purified plasmid 
was used for nucleotide sequencing. 5 µL of eluted plas-
mid was subjected to cycle sequencing with 1.0 µL of the 
ABI Prism BigDye terminator cycle sequencing ready 
reaction kit (ABI) using 0.5  µL of 5′AOX-F: 5′-GACTG 
GTTCCAATTGACAAGC-3′ on the AOX1 promoter 
and 3′AOX1-R: 5′-GCAAATGGCATTCTGACATCC-3′ 
on the AOX1 terminator. Consensus sequences were gen-
erated by alignment of both sequenced strands after vali-
dation using DNAstar software V7.
Expression of recombinant S‑HDAg in P. pastoris
Plasmid preparation A positive colony of E. coli was 
cultured at 37 °C overnight in 50 mL liquid LB medium 
supplemented with 25  μg/mL Zeocin. The recombinant 
plasmid (pPICAαA-S-HDAg) was then isolated by Gen-
Elute Plasmid Midiprep kit (Sigma-Aldrich, NA0200) 
following the manufacturer’s instructions and linearized 
using PmeI (NEB, R0560S). The linearized plasmid was 
then separated on a 1.5% agarose gel and purified by Wiz-
ard SVGel and PCR Clean-Up System (Promega, A9281) 
following the manufacturer’s instructions.
Transformation and screening of yeast
Transformation 5 μg of the linearized recombinant vec-
tor was transformed into 50 µL of competent P. pastoris 
X33 or SMD1163 cells using a Gene-pulser electroporator 
(Bio-Rad) at 1800 V (25 µF, 600 Ω) in a 10 mm gap elec-
troporator cuvette. After adding 1 mL 1 M ice-cold sorbi-
tol, the cells were recovered at 30 °C for 2 h. 100 µL of the 
transformation mixture were then plated on YDPS plates 
supplemented with 100, 500 and 1000  µg/mL Zeocin 
and then incubated at 30  °C for 2–3 days until colonies 
appeared.
Induction on a small scale For expression screening, 24 
colonies of each parent strain, X33 or SMD1163, were 
cultured at 30  °C in 2.5  mL liquid BMGY media with-
out Zeocin in a Micro-24 plate (Corning) to  A600 around 
15–20. Cells were centrifuged and transferred to 10 mL 
induction BMMY medium. Cells and culture media were 
harvested every 24-h post-induction. 1% methanol was 
added every 24-h post-induction.
Secreted protein preparation Cultures were centrifuged 
at 5000 rpm for 3 min and 20 µL of the supernatant was 
taken forward for immunoblot analysis.
Intracellular protein preparation Cell pellets were used 
to determine total, intracellular protein. 1  mL break-
ing buffer (50 mM  Na2HPO4, 50 mM  NaH2PO4, 2.0 mM 
EDTA, pH 7.4, 100 mM NaCl and 5% glycerol; pH 7.4), 
2.0 µL protease inhibitor (Calbiochem) and 200 mg glass 
bead were added to the cell pellets. The cells were then 
lysed by breaking at 50 Hz for 3 min in a Tissue Lyser LT 
(Qiagen). The supernatant was transferred to a 1.5  mL 
Eppendorf and centrifuged at 13,000 rpm for 15 min. The 
cell lysate was used for immunoblot analysis.
Immunoblot For detection of the HDAg-His-tag fusion 
protein, immunoblotting was used to detect the  His6-tag 
fused to the HDAg protein in the supernatant (culture 
medium) or intracellular protein (cell lysate). 20 µL (10 µg) 
of each sample and 5 µL Protomarker pre-stained protein 
ladder (National Diagnostics) (10–225 kDa) were applied 
onto a 12.5% SDS gel and run in 1× Tris/glycine/SDS 
(GeneFlow) at 100 V for 1 h. The SDS gel was transferred 
on to a nitrocellulose membrane (Whatman, 09-301-111), 
blocked in 5% milk in 1× PBS buffer and incubated with 
primary antibody (6× His monoclonal antibody (Serotec) 
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at a 1:5000 dilution at room temperature for 1 h). After 
washing with 1× PBST, the membrane was incubated 
with secondary antibody against mouse IgG conjugated 
with HRP (Sigma, A0545) at a 1:5000 dilution for 1 h. 
After washing with 1× PBST, protein bands on the mem-
brane were detected using EZ-ECL chemiluminescence 
solution (Geneflow, 20-500-120) and visualized using a 
Uvitec instrument.
Nickel affinity purification
Recombinant protein was purified a using a His-trap col-
umn. Total secreted protein from 300 mL culture broth was 
dialyzed against binding buffer (300 mM NaCl, 10 mM imi-
dazole, 50  mM  NaH2PO4, pH 8.0; Sigma-Aldrich, 56750) 
which was also used as the binding and equilibration solu-
tion. A 5  mL His-trap HP column (GE Healthcare) was 
equilibrated with 5 column volumes of binding buffer. All 
dialyzed protein (5 mg) was loaded into the column with a 
flow rate of 1 mL/min for 50 min. The column was washed 
with 5 column volumes of binding buffer followed by 5 col-
umn volumes of wash buffer (300 mM NaCl, 30 mM imi-
dazole, 50 mM  NaH2PO4, pH 8.0). The protein was eluted 
with elution buffer (300  mM NaCl, 250  mM imidazole, 
50 mM  NaH2PO4, pH 8.0) at a flow rate of 1 mL/min for 
20  min. Each 1  mL fraction was analyzed by SDS-PAGE 
and visualized using a silver staining kit (Sigma-Aldrich). 
The protein concentration of the eluted fractions was quan-
tified using a Bradford kit (BioBasic).
Results
Cloning and sequencing
A 589  bp fragment comprising the HDAg gene was 
amplified by PCR (Fig.  1a). The PCR amplicon was 
cloned into the vector pPICZαA by enzymatic diges-
tion and ligation. To confirm this, the recombinant vec-
tor pPICZαA-S-HDAg was digested with XbaI and KpnI. 
Two bands of 589 and 3567 bp in length were produced 
as expected (Fig. 1b, c). To ensure the S-HDAg gene was 
in frame, two primers 5′AOX1-F and 3′AOX1-R were 
used for sequencing a segment of the recombinant vec-
tor pPICZαA-S-HDAg (Fig. 1d). As shown in Fig. 1e, the 
HDAg gene was cloned into vector pPICZαA and located 
between the α-factor at the 5′-end and the hexa histidine-
tag at the 3′-end. The linearized recombinant vector 
pPICZαA/S-HDAg was transformed into freshly-pre-
pared competent P. pastoris X33 or SMD1163 cells. Posi-
tive colonies were screened based on their resistance to 
Zeocin due to expression of the Zeocin resistance gene.
Protein expression and purification
To test the expression levels of the HDAg-His-tag fusion 
protein, 24 positive colonies of each yeast strain were 
cultured in 2.5  mL BMGY media in a Micro-24 micro-
plate and transferred into 10  mL BMMY supplemented 
with 1% v/v methanol as an inducer at three time points: 
24, 48 and 72  h of induction. Under the control of the 
promoter AOX1 (methanol inducible promoter), the 
S-HDAg gene was expressed in P. pastoris X33 but not 
in SMD1163. For the X33 strain, the expressed protein 
signal was detected in the culture medium after 48 and 
72  h of induction, while no signal was detected in the 
cell lysate at all three induction time points. A clear band 
at 25 kDa was observed by immunoblot (Fig. 2). This is 
the expected size of the recombinant protein includ-
ing α-factor, S-HDAg, c-myc epitope, and  His6-tag. The 
recombinant protein was purified exploiting its fused 
 His6-tag. The protein eluted at imidazole concentra-
tions from 108–144  mM (wells 4–7, Fig.  3), but not at 
other concentrations (data not shown). This protein had 
a molecular weight of 25 kDa which is similar to the pre-
dicted molecular weight of the recombinant protein. The 
yield of purified protein was 115 µg/L culture medium.
Discussion
S-HDAg may present a good candidate for HDV vac-
cine development and for diagnostic assays of HDV, but 
its characterization and immunological evaluation are 
still limited. One reason is that expression and purifica-
tion are not effective [12]. For example, expression of 
the S-HDAg protein has been performed in several cells 
including E. coli [13, 14] and baculovirus/insect cells. 
However, the former lacks the systems for post-transla-
tional modifications and the latter results in rapid deg-
radation of the HDAg protein after 2 days post-infection 
[12, 15]. The insertion of the HDAg gene into the chro-
mosome of animal cells resulting in a stable cell-line is a 
good choice, but this is yet to be reported because HDAg 
is a nuclear protein and the accumulation of this protein 
results in significant cytotoxicity. In 1990, a number of 
HDAg-positive HeLa clones were developed, but these 
cells were lost in culture, whereas a proportion of HDAg-
positive HepG2 clones were expanded successfully [16], 
suggesting that HDAg cytotoxicity may contribute to the 
cytopathic nature of HDV that was postulated previously 
[17]. Transient expression in mammalian cells mediated 
by viral systems (e.g. vaccinia virus) may be possible as 
well, however these viruses result in cell death and lysis.
Post-translational modifications have been demon-
strated to participate in modulating properties and 
functions of several proteins [18, 19]. HDAg has been 
identified as being post-translationally modified, which 
is important for its RNA replication and cellular localiza-
tion [20]. Yeast expression systems in general, and in par-
ticular P. pastoris, have several advantages such as being 
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able to perform eukaryotic post-translational modifi-
cations. In this study, the HDAg antigen was expressed 
for the first time in P. pastoris and secreted into the cul-
ture medium, which aids in purification of the protein. 
This preliminary finding will aid further studies of the 
S-HDAg protein.
Limitations
Our study had some limitations. We examined the expres-
sion of only one HDAg isoform, S-HDAg, in P. pastoris. 
We also did not address scale-up of the recombinant pro-
tein. Finally, we did not characterize the immunological 
properties of the purified recombinant HDAg protein.
Fig. 1 Cloning of the S‑HDAg gene in the vector pPICZαA. a An agarose gel image showing the PCR product. The arrow indicates the position of 
the PCR product. b An agarose gel image showing the vector pPICZαA. The arrow indicates the position of the vector pPICZαA. c An agarose gel 
image showing the recombinant vector pPICZαA‑S‑HDAg isolated from five E. coli colonies (lanes 1–5) cut by XbaI and KpnI. d Diagrammatic map of 
the recombinant vector pPICZαA‑S‑HDAg (drawn using the Clone Manager Suite). e A partial sequence of the recombinant vector pPICZαA‑S‑HDAg 
including the α‑factor, the S‑HDAg gene, and  His6‑tag (using DNA star software). The arrows indicate the positions of the vector pPICZαA and the 
S‑HDAg gene, respectively. M GeneRuler 1 kb plus DNA ladder (Fermentas)
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